Subscribe to RSS

DOI: 10.1055/s-0045-1806930
Prognostic Value of Beclin-1 and HIF-1α in Oral Squamous Cell Carcinoma
Authors

Abstract
Objectives Certain factors that disturb the tumor microenvironment influence the promotion of tumorigenesis. Detecting gene expression at the protein level is highly valuable and complements the histopathological analysis achieved by immunohistochemistry (IHC). Hypoxia-inducible factor (HIF)-1α accomplishes autophagy induction and regulation of autophagy-associated genes. So, this study was carried out to evaluate the tissue protein expression of Beclin-1 and HIF-1α using IHC and correlate their expression with the prognosis of oral squamous cell carcinoma (OSCC).
Materials and Methods Immunohistochemical evaluation of Beclin-1 and HIF-1α was done in 5 samples of normal oral epithelial tissues and 45 samples of OSCC, which were classified histologically into 15 samples each of well, moderately, and poorly differentiated squamous cell carcinoma.
Results According to statistics, normal tissue had the highest values for Beclin-1, while poorly differentiated OSCC had the lowest mean area percentage. HIF-1α showed the opposite results. These results indicate that the association of both molecules has a greater role in the transformation from normal to different histopathological grades of OSCC.
Conclusion The close association between Beclin-1 and HIF-1α identified in the current study confirms hypoxia's critical role in autophagy activation. Moreover, reduced Beclin-1 and elevated HIF-1α expression were significantly associated with the histopathological grading of OSCC, supporting their pivotal role in the development and progression of OSCC.
Note
This work has been performed at the Faculty of Dental Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Publication History
Article published online:
23 July 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Tan Y, Wang Z, Xu M. et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci 2023; 15 (01) 44
- 2 Pekarek L, Garrido-Gil MJ, Sánchez-Cendra A. et al. Emerging histological and serological biomarkers in oral squamous cell carcinoma: applications in diagnosis, prognosis evaluation and personalized therapeutics (review). Oncol Rep 2023; 50 (06) 213
- 3 Nethan ST, Gupta S, Warnakulasuriya S. Risk factors for oral squamous cell carcinoma in the Indian population. In: Microbes and Oral Squamous Cell Carcinoma: A Network Spanning Infection and Inflammation. Singapore: Springer Nature Singapore; 2022: 9-40
- 4 Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 2018; 15 (02) 81-94
- 5 Cao LM, Zhong NN, Li ZZ. et al. Lymph node metastasis in oral squamous cell carcinoma: where we are and where we are going. Clin Transl Discov 2023; 3 (04) e227
- 6 Budach V, Tinhofer I. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol 2019; 20 (06) e313-e326
- 7 Hsieh JC, Wang HM, Wu MH. et al. Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy. Head Neck 2019; 41 (Suppl. 01) 19-45
- 8 Zaarour RF, Azakir B, Hajam EY. et al. Role of hypoxia-mediated autophagy in tumor cell death and survival. Cancers (Basel) 2021; 13 (03) 533
- 9 Satija S, Kaur H, Tambuwala MM. et al. Hypoxia-inducible factor (HIF): fuel for cancer progression. Curr Mol Pharmacol 2021; 14 (03) 321-332
- 10 Zhang Q, Han Z, Zhu Y, Chen J, Li W. Role of hypoxia inducible factor-1 in cancer stem cells (review). Mol Med Rep 2021; 23 (01) 17
- 11 Gentile D, Esposito M, Grumati P. Metabolic adaption of cancer cells toward autophagy: is there a role for ER-phagy?. Front Mol Biosci 2022; 9: 930223
- 12 Alabiad M, Harb O, Mandour D. et al. Prognostic and clinicopathological implications of expression of Beclin-1 and hypoxia-inducible factor 1α in serous ovarian carcinoma: an immunohistochemical study. Pol J Pathol 2021; 72 (01) 23-38
- 13 Turek K, Jarocki M, Kulbacka J, Saczko J. Dualistic role of autophagy in cancer progression. Adv Clin Exp Med 2021; 30 (12) 1303-1314
- 14 Lin W, Yin CY, Yu Q. et al. Expression of glucose transporter-1, hypoxia inducible factor-1α and beclin-1 in head and neck cancer and their implication. Int J Clin Exp Pathol 2018; 11 (07) 3708-3717
- 15 Kocaturk NM, Gozuacik D. Crosstalk between mammalian autophagy and the Ubiquitin-Proteasome System. Front Cell Dev Biol 2018; 6: 128
- 16 Prerna K, Dubey VK. Beclin1-mediated interplay between autophagy and apoptosis: new understanding. Int J Biol Macromol 2022; 204: 258-273
- 17 Hu Z, Zhong Z, Huang S. et al. Decreased expression of Beclin-1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma. Mol Med Rep 2016; 14 (02) 1567-1573
- 18 Hu YJ, Zhong JT, Gong L, Zhang SC, Zhou SH. Autophagy-related Beclin 1 and head and neck cancers. OncoTargets Ther 2020; 13: 6213-6227
- 19 Barca I, Mignogna C, Novembre D, Ferragina F, Cristofaro MG. Immunohistochemical analysis of the Beclin-1 expression predicts the progression of rral squamous cell carcinoma. Int J Environ Res Public Health 2021; 18 (21) 11125
- 20 Zheng HC, Zhao S, Xue H, Zhao EH, Jiang HM, Hao CL. The roles of Beclin 1 expression in gastric cancer: a marker for carcinogenesis, aggressive behaviors and favorable prognosis, and a target of gene therapy. Front Oncol 2020; 10: 613679
- 21 Shin JY, Hong SH, Kang B, Minai-Tehrani A, Cho MH. Overexpression of beclin1 induced autophagy and apoptosis in lungs of K-rasLA1 mice. Lung Cancer 2013; 81 (03) 362-370
- 22 Sumera S, Ali A, Yousafzai YM. et al. Overexpression of hypoxia-inducible factor-1α and its relation with aggressiveness and grade of oral squamous cell carcinoma. Diagnostics (Basel) 2023; 13 (03) 451
- 23 Patel NR, Jain L, Mahajan AM, Hiray PV, Shinde SS, Patel PA. An immunohistochemical study of HIF-1 alpha in oral epithelial dysplasia and oral squamous cell carcinoma. Indian J Otolaryngol Head Neck Surg 2019; 71 (04) 435-441
- 24 Yfantis A, Mylonis I, Chachami G. et al. Transcriptional response to hypoxia: the role of HIF-1-associated co-regulators. Cells 2023; 12 (05) 798
- 25 Arjmand MH, Moradi A, Rahimi HR. et al. Prognostic value of HIF-1α in digestive system malignancies: evidence from a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench 2022; 15 (02) 108-119
- 26 Zhao Z, Mu H, Li Y, Liu Y, Zou J, Zhu Y. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients. Clin Transl Oncol 2020; 22 (10) 1892-1906
- 27 Lee SJ, Kim HP, Jin Y, Choi AM, Ryter SW. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Autophagy 2011; 7 (08) 829-839
- 28 Wan XB, Fan XJ, Chen MY. et al. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy 2010; 6 (03) 395-404
- 29 Dong M, Wan XB, Yuan ZY. et al. Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Med Oncol 2013; 30 (01) 355